Literature DB >> 36106071

Ovarian steroid cell tumor associated with von Hippel-Lindau syndrome: a report of two cases and literature review.

Yulan Gong1, Suad Taraif2, Iryna Mazur2, Amandeep Aneja2, Min Huang1, Debra L Somers3, Jian J Fu2.   

Abstract

Steroid cell tumor (SCT) is a rare sex cord-stromal tumor accounting for only 0.1% of ovarian tumors. Steroid cell tumor, not otherwise specified (SCT, NOS) is of uncertain lineage and is the most common among the three subtypes of SCT. Patients often present with endocrine abnormalities. Von Hippel-Lindau (VHL) syndrome is an autosomal dominant disorder resulting from inactivating gene deletions, frameshifts, and missense mutations of the VHL gene. VHL syndrome can involve multiple organs and clinically is subclassified into type 1 and type 2 based on the risk of pheochromocytoma (PCC). The association of VHL syndrome with genital tract tumors is rare, and here we report two cases of SCT, NOS in patients with VHL disease. The first case is a 19-year old female with VHL and prior resection of bilateral cerebellar hemangioblastomas. During the radiological surveillance, she was found to have multiple small enhancing foci in the cerebellar hemispheres and a stable small enhancing focus in the T6 cord with associated edema, likely reflecting a small hemangioblastoma. She had long history of irregular menses and ultrasound of pelvis found a large right ovarian mass. Cystectomy specimen showed a 6.4 cm well-circumscribed lesion with yellow cut surface. Histologic examination and immunohistochemical staining confirmed the diagnosis of SCT, NOS. The second patient is a 39-year-old female with VHL, previous surgery for retinal hemangioblastomatosis and cerebellar hemangioblastoma, history of abnormal uterine bleeding and elevated testosterone. CT of abdomen and pelvis revealed bilateral multiple cystic and solid renal lesions and a large left ovarian complex cyst. Bilateral partial nephrectomy showed multiple renal cysts and clear cell renal cell carcinomas (RCCs). Left salpingo-oophorectomy showed a 7 cm lesion with yellow-orange cut surface and features consistent with SCT, NOS. Review of the previously reported VHL SCT cases (not including the current two cases) indicated a probable link between VHL syndrome and SCT. IJCEP
Copyright © 2022.

Entities:  

Keywords:  Ovarian steroid cell tumor; histological examination; immunohistochemistry; von Hippel-Lindau syndrome

Year:  2022        PMID: 36106071      PMCID: PMC9441858     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  12 in total

1.  An analysis of five clear cell papillary cystadenomas of mesosalpinx and broad ligament: four associated with von Hippel-Lindau disease and one aggressive sporadic type.

Authors:  Francisco F Nogales; Pablo Goyenaga; Ovidiu Preda; Alina Nicolae; Begoña Vieites; Maria Carmen Ruiz-Marcellan; Alberto Pedrosa; Maria J Merino
Journal:  Histopathology       Date:  2012-02-01       Impact factor: 5.087

2.  Ovarian steroid cell tumors (not otherwise specified). A clinicopathological analysis of 63 cases.

Authors:  M C Hayes; R E Scully
Journal:  Am J Surg Pathol       Date:  1987-11       Impact factor: 6.394

3.  Clear cell papillary cystadenoma of the epididymis and mesosalpinx: immunohistochemical differentiation from metastatic clear cell renal cell carcinoma.

Authors:  Hakan Aydin; Robert H Young; Brigitte M Ronnett; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2005-04       Impact factor: 6.394

4.  Allelic Deletion of VHL Gene Detected in Papillary Tumors of the Broad Ligament, Epididymis, and Retroperitoneum in von Hippel-Lindau Disease Patients.

Authors:  Ting Shen; Zhengping Zhuang; Deborash J. Gersell; Fattaneh A. Tavassoli
Journal:  Int J Surg Pathol       Date:  2000-07       Impact factor: 1.271

5.  Genetic analysis of von Hippel-Lindau disease.

Authors:  Morgan Nordstrom-O'Brien; Rob B van der Luijt; Ellen van Rooijen; Ans M van den Ouweland; Danielle F Majoor-Krakauer; Martijn P Lolkema; Aram van Brussel; Emile E Voest; Rachel H Giles
Journal:  Hum Mutat       Date:  2010-05       Impact factor: 4.878

Review 6.  Ovarian Steroid Cell Tumor in an Adolescent With Von Hippel-Lindau Syndrome: A Case Report and Review of the Literature.

Authors:  Ana Marques; Raquel Portugal
Journal:  Int J Gynecol Pathol       Date:  2020-09       Impact factor: 2.762

7.  Ovarian steroid cell tumors: an immunohistochemical study including a comparison of calretinin with inhibin.

Authors:  Michael T Deavers; Anais Malpica; Nelson G Ordonez; Elvio G Silva
Journal:  Int J Gynecol Pathol       Date:  2003-04       Impact factor: 2.762

8.  Lipid cell tumors in two women with von Hippel-Lindau syndrome.

Authors:  Marnie Wagner; Hyacinth N Browne; W Marston Linehan; Maria Merino; Nabeel Babar; Pamela Stratton
Journal:  Obstet Gynecol       Date:  2010-08       Impact factor: 7.623

9.  Genotype-phenotype relations of the von Hippel-Lindau tumor suppressor inferred from a large-scale analysis of disease mutations and interactors.

Authors:  Giovanni Minervini; Federica Quaglia; Francesco Tabaro; Silvio C E Tosatto
Journal:  PLoS Comput Biol       Date:  2019-04-03       Impact factor: 4.475

10.  Steroid Cell Ovarian Tumor in a Case of von Hippel-Lindau Disease: Demonstrating Lipid Content of the Mass with MR Imaging.

Authors:  Ajaykumar C Morani; Ahmad Iyad Mubarak; Hrishabh R Bhosale; Nisha S Ramani; Steven G Waguespack; Anita Ying
Journal:  Magn Reson Med Sci       Date:  2019-01-31       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.